Children born to HIV-1-infected women in Sweden in 1982-2003 -: Trends in epidemiology and vertical transmission

被引:41
作者
Naver, Lars [1 ]
Lindgren, Susanne
Belfrage, Erik
Gyllensten, Katarina
Lidman, Knut
Gisslen, Magnus
Ehrnst, Anneka
Arneborn, Malin
Bohlin, Ann-Britt
机构
[1] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Div Pediat,Dept Clin Sci Intervent & Technol, SE-14186 Stockholm, Sweden
[2] Karolinska Univ, Huddinge Hosp, Dept Obstet & Gynecol, SE-14186 Stockholm, Sweden
[3] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Women & Child Hlth, SE-14186 Stockholm, Sweden
[4] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-14186 Stockholm, Sweden
[5] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Med,Unit Infect Dis, SE-14186 Stockholm, Sweden
[6] Sahlgrens Univ Hosp, Dept Infect Dis, S-41345 Gothenburg, Sweden
[7] Swedish Inst Infect Dis, Stockholm, Sweden
关键词
HIV-1; mother-to-child transmission; prophylactic intervention; antenatal screening;
D O I
10.1097/01.qai.0000224571.30119.3d
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To describe the HIV-1 epidemic among childbearing women and their children in Sweden, a population-based analysis of data on all known mother-child pairs in Sweden with perinatal exposure to HIV-1 1982-2003 was conducted. The mother-to-child transmission (MTCT) rate in children prospectively followed from birth decreased from 24.7% in 1985-1993 to 5.7% in 1994-1998 and 0.6% in 1999-2003. The use of antiretroviral treatment of the mother during pregnancy and/or prophylactic antiretroviral intervention increased from 2.3% to 91.6% during the same period, and the elective cesarean delivery rate increased from 8.0% to 80.3%. No MTCT of HIV-1 occurred in Sweden after 1999. Fifty-one vertically HIV-1-infected children aged 2.7 to 17.6 years were living in Sweden by 31 December 2003, 71% being treated with antiretroviral agents. No HIV-1-related child death has been reported in Sweden after 1996. The conclusion is that MTCT of HIV-1 can be almost eliminated when appropriate resources are available. A national pregnancy screening program for HIV-1 running since 1987 with a high acceptance rate and the implementation of measures to prevent MTCT since 1994 have resulted in a significant decrease in the number of infected children. Inasmuch as knowledge of the infection status of the mother is crucial for reduction in MTCT of HIV-1, continued antenatal screening is important even in a low-prevalence country such as Sweden.
引用
收藏
页码:484 / 489
页数:6
相关论文
共 20 条
[1]   The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 -: A meta-analysis of 15 prospective cohort studies [J].
Andiman, W ;
Boucher, M ;
Burns, D ;
Bryson, Y ;
Farley, J ;
Fowler, H ;
Gabiano, C ;
Galli, L ;
Hutto, C ;
Kind, C ;
Korber, B ;
Kovacs, A ;
Krogstad, P ;
Landesman, S ;
Lapointe, N ;
Lemay, M ;
Lew, J ;
Mandelbrot, L ;
Mayaux, MJ ;
Mellins, R ;
Minkoff, H ;
Mofenson, L ;
Nielsen, K ;
Newell, ML ;
Pardi, G ;
Peavy, H ;
Peckham, C ;
Read, J ;
Rother, C ;
Rudin, C ;
Scott, G ;
Semprini, A ;
Shearer, W ;
Simonds, R ;
Simpson, B ;
Stek, A ;
Tovo, PA ;
Tuomala, R ;
Van Dyke, R ;
Weedon, J ;
de Martino, M ;
Lindsay, M ;
Belair, S ;
Chan, L ;
Harris, D ;
Kalish, L ;
Muenz, L ;
Nugent, R ;
Schluchter, M ;
Durako, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (13) :977-987
[2]  
[Anonymous], 1994, Morbidity and Mortality Weekly Report, V43, P1
[3]   Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival [J].
Bardeguez, AD ;
Shapiro, DE ;
Mofenson, LM ;
Coombs, R ;
Frenkel, LM ;
Fowler, MG ;
Huang, S ;
Sperling, RS ;
Cunningham, B ;
Gandia, J ;
Maupin, R ;
Zorrilla, CD ;
Jones, T ;
O'Sullivan, MJ .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (02) :170-181
[4]  
*CDCP, 1992, MMWR MORB MORTAL WKL, V41
[5]   The efficacy and tolerability of combination antiretroviral therapy in pregnancy: infant and maternal outcome [J].
Clarke, SM ;
Mulcahy, F ;
Healy, CM ;
Condon, S ;
Butler, KM .
INTERNATIONAL JOURNAL OF STD & AIDS, 2000, 11 (04) :220-223
[6]  
Comm Obstet Practice, 2001, INT J GYNECOL OBSTET, V73, P279
[7]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[8]  
Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009
[9]  
*EUR COLL STUD, 2004, AIDS CARE, V3, P293
[10]  
GARCIA PM, 1993, NEW ENGL J MED, V341, P394